According to foreign reports, ADICON, a mainland medical laboratory invested by Carlyle Group, a US private equity fund, is discussing listing plans with its financial advisers. It is expected to list in Hong Kong as soon as the end of this year, and plans to raise $300 million to $400 million (about HK $2.34 billion to HK $3.12 billion). Established on January 8, 2004, adikang Medical Laboratory Center Co., Ltd. is an independent medical laboratory operated by chain operation in China, and has set up more than 20 medical laboratories in China. At present, aidicom has 5 central laboratories and R & D centers for clinical, pathological, reproductive genetic, gene testing and clinical trials. It has more than 20 professional clinical laboratories, providing more than 2000 testing items. < / P > < p > as early as 2018, the global alternative asset management enterprise Carlyle investment group (CG) joined hands with meinian Health Industry Holding Co., Ltd. to jointly participate in aidicom medicine. It is understood that the round of investment funds come from Carlyle Asia Fund V (Phase V), and Carlyle Investment Group has become the largest shareholder of aidicom after the investment.